In early 2020, surgeons at the OHSU Casey Eye Institute performed the first in-body CRISPR gene editing procedure as part of the Phase 1/2 BRILLIANCE clinical trial. Now, new trial results show about 79% of the 14 trial’s participants with a rare form of inherited blindness had measurable improvement after receiving an experimental, CRISPR-based gene editing treatment. (OHSU/Kristyna Wentz-Graff)

In early 2020, surgeons at the OHSU Casey Eye Institute performed the first in-body CRISPR gene editing procedure as part of the Phase 1/2 BRILLIANCE clinical trial. Now, new trial results show about 79% of the 14 trial’s participants with a rare form of inherited blindness had measurable improvement after receiving an experimental, CRISPR-based gene editing treatment. (OHSU/Kristyna Wentz-Graff)

For the first time since the COVID-19 pandemic began, the OHSU School of Medicine will offer a hybrid Match Day celebration for its M.D. class of 2022. The class’ 149 members will either participate in person or virtually to learn where they will spend the next three to seven years as medical resident physicians. Shown here is OHSU’s 2019 Match Day festivities, which was the last time the university held the event in person. (OHSU/Kristyna Wentz-Graff)

Oregon Health & Science University will hold its first in-person convocation in two years on Sunday, June 5, 2022. After the COVID-19 pandemic forced the annual tradition to go virtual, the university is offering both an in-person and a remote participation option in 2022. Shown here are graduates celebrating during the 2016 convocation ceremony. (OHSU/John Valls)